EUPRAXIA PHARMACEUTICALS INC. Nontrade Receivables, Current
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Nontrade Receivables, Current of $674.23 thousand as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:NontradeReceivablesCurrent · last filed 2026-03-13
- 2025-12-31: Nontrade Receivables, Current $674.23K.
- 2024-12-31: Nontrade Receivables, Current $228.87K.
- 2023-12-31: Nontrade Receivables, Current $190.61K.
- 2022-12-31: Nontrade Receivables, Current $89.72K.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2025-12-31 | $674.23K 40-F · filed 2026-03-13 |
| 2024-12-31 | $228.87K 40-F · filed 2026-03-13 |
| 2023-12-31 | $190.61K 40-F · filed 2025-03-20 |
| 2022-12-31 | $89.72K 40-F · filed 2024-04-01 |